GENE ONLINE|News &
Opinion
Blog

Phase 3 Trial
R&D
Study Shows Bayer’s Aliqopa, Rituximab Combo Improves Survival of Relapsed Lymphoma Patients
2021-04-10
FDA Rejects Athenex’s Breast Cancer Treatment, Recommends Another Clinical Trial
2021-03-03
AZ’s Immune Checkpoint Inhibitor Flunks Head and Neck Cancer Trial
2021-02-10
Johnson & Johnson’s COVID-19 Vaccine Draws Mixed Reactions as it Registers 66% Efficacy
2021-01-31
FDA Approves Second Lupus Nephritis Drug in Two Months
2021-01-25
Alnylam Nears Fourth Approval with Successful Trial Data for RNAi Drug
2021-01-08
Lynparza Bags Multiple Approvals in Japan
2021-01-05
Amgen and AstraZeneca’s Asthma Drug Flunks Phase 3 Trial
2020-12-26
Spotlight: Novartis’ Kisqali Shows Promising Results in Metastatic Breast Cancer
2020-12-18
Novartis Announces Failure of Ruxolitinib Trial in Severe COVID-19
2020-12-18
Ionis Initiates Phase 3 Trials for Familial Chylomicronemia Syndrome Treatment
2020-12-06
Agios Pharmaceuticals’ Lead Candidate Mitapivat Achieves Primary Endpoint in ACTIVATE Trial
2020-12-03
FDA Requests Additional Info for Liquidia’s Pulmonary Arterial Hypertension Treatment
2020-11-27
Cheaper and Fridge-Stable AstraZeneca Vaccine is 90% Effective in Preventing COVID-19
2020-11-23
uniQure’s Gene Therapy Impresses in Pivotal Trial Raising Hopes of a Hemophilia B Cure
2020-11-22
1 2 3 4 6
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top